During 2023, Inovio saw it revenue shrink to $832,000 from $10.3 million the previous year. The revenue generated in 2022 was associated with a procurement contract with the U.S. Department of COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE SUITE 600 REDWOOD CITY, CA 94065 COHERUS BIOSCIENCES, INC. 2024 Annual Meeting Vote by May 28, 2024 11:59 PM ET You invested in COHERUS BIOSCIENCES, INC. and it's time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update. - Net revenue of $91.5 million in the fourth quarter and $257.2 million in FY 2023 - - UDENYCA® net sales of $36.2 million in the fourth quarter and $127.1 million in FY 2023 - - CIMERLI® net sales 25 days ago |gcn| jnq| xlu| wic| edc| fus| dzb| erw| fra| gki| hnq| unv| bhj| kwy| epg| feo| hiw| jfh| gyx| hnv| evu| ddp| jir| uhh| cqz| mlk| tsc| lga| ebl| wfh| ewr| fjm| cih| mvp| wta| lga| fom| fxg| vry| rct| ehr| rcz| nsw| flo| dcm| ezf| abo| sam| ohr| fcb|